Wiley Blackwell

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Yahalom
    Yahalom
  3. Palomba
    Palomba
  4. Salles
    Salles
  5. Moskowitz
    Moskowitz
  6. Imber
    Imber
  7. Zelenetz
    Zelenetz
  8. Kumar
    Kumar
  9. Noy
    Noy
  10. Hamlin
    Hamlin

Groups

  1. Hematologic Malignancies, Division of (170)
  2. Department of Medicine (167)
  3. Center for Hematologic Malignancies (134)
  4. Lymphoma (110)
  5. Survivorship Research (55)
  6. Hematology-Oncology Fellows (40)
  7. Population Sciences Research Program (38)
  8. Radiation Oncology, Department of (35)
  9. Sloan Kettering Institute Postdocs (31)
  10. Executive Committee, Center for Hematologic Malignancies (26)
Search Within
  1. "Hematological Oncology"
Formats
  1. Meeting Abstract (175)
  2. Journal Article (13)
  3. Review (5)
  4. Conference Paper (4)
  5. Research Letter (2)
Groups
  1. Hematologic Malignancies, Division of (170)
  2. Department of Medicine (167)
  3. Center for Hematologic Malignancies (134)
  4. Lymphoma (110)
  5. Survivorship Research (55)
  6. Hematology-Oncology Fellows (40)

More Groups

People
  1. Steven Horwitz (38)
  2. Joachim Yahalom (34)
  3. Maria Palomba (30)
  4. Gilles Salles (28)
  5. Alison Moskowitz (23)
  6. Anas Younes (22)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (66)
  4. 2022 (3)
  5. 2021 (32)
  6. 2020 (2)

More Years

Publications
  1. Hematological Oncology (199)

Results (199)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of age on biology, presentation and outcomes in marginal zone lymphoma: Results from a multicenter cohort study
    Journal Article

    Torka, P.; Grover, N. S.; Voorhees, T. J.; Karmali, R.; Annunzio, K.; Watkins, M. P.; Anampa-Guzmán, A.; Reves, H.; Tavakkoli, M.; Christian, B.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Targeting of PIM kinases shows single agent efficacy and synergizes with BCL2 inhibitors in diffuse large B cell lymphoma of the ABC subtype
    Journal Article

    Tarantelli, C.; Kayali, O.; Civanelli, E.; Cascione, L.; Mensah, A. A.; Folloni, C.; Arribas, A. J.; Rinaldi, A.; Cmiljanovic, V.; Mondello, P.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Impact of recent translational and therapeutic developments on clinical course of BCR::ABL1-positive and -negative myeloproliferative neoplasms
    Review

    Mughal, T. I.; Mascarenhas, J.; Rampal, R. K.; Bose, P.; Lion, T.; Ajufo, H.; Yacoub, A.; Meshinchi, S.; Masarova, L.; Mesa, R.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse
    Review

    Ghione, P.; Lewis, K. L.; Bobillo, S.; Nayak, L.; Schorb, E.; Nichelli, L.; Ng, A.; Savage, K. J.; McKay, P.; Nastoupil, L.; more...
    Hematological Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
    Research Letter

    Le Lan, C.; Belot, A.; Golfier, C.; Audin, B.; Sesques, P.; Bernier, A.; Safar, V.; Ferrant, E.; Lazareth, A.; Lequeu, H.; more...
    Hematological Oncology (2024)

    Fulltext@MSK | Save
  • TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (LISO‐CEL) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
    Meeting Abstract

    Morschhauser, F.; Dahiya, S.; Palomba, M. L.; Garcia‐Sancho, A. M.; Reguera Ortega, J. L.; Kuruvilla, J.; Jager, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 3 trial of subcutaneous epcoritamab + R‐CHOP versus R‐CHOP in patients (pts) with newly diagnosed diffuse large B‐cell lymphoma (DLBCL): EPCORE DLBCL‐2
    Meeting Abstract

    Sehn, L. H.; Chamuleau, M.; Lenz, G.; Clausen, M. R.; Haioun, C.; Izutsu, K.; Davies, A.; Zhu, J.; Oki, T.; Szafer‐Glusman, E.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel (LISO‐CEL) in R/R MCL: Primary analysis results from the MCL cohort of the single-arm, multicenter, seamless design transcend NHL 001 study
    Meeting Abstract

    Wang, M.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Daratumumab and EPOCH for HIV+/‐ plasmablastic lymphoma: A feasibility study of the AIDS Malignancy Consortium (AMC 105)
    Meeting Abstract

    Noy, A.; Barta, S. K.; Tan, C. R.; Kwon, D.; Baiocchi, R.; Rubinstein, P.; Ambinder, R.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Upfront radiation therapy for post-stem cell transplant multiple myeloma patients with oligo‐relapse/progressive disease: Factors associated with favorable outcomes
    Meeting Abstract

    Fregonese, B.; Dreyfuss, A.; Imber, B.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save